• Biopsy, Bone
  • Noonan Spectrum Disorders Gene Mutation Panel, NGS
  • Immunoglobulin A (IgA)
  • MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • Francisella tularensis Antibody, IgM
  • Basic Metabolic Panel (BMP)
  • Carbamazepine Screening, Urine
  • Biopsy, Lymph Node
  • Maternal Screening, Sequential
  • Osmolality, Body Fluid
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Specimen Collection
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.